No abstract available
Keywords:
5-azacytidine; ATRA; acute myeloid leukemia; biomodulatory therapy; pioglitazone.
MeSH terms
-
Aged
-
Antimetabolites, Antineoplastic / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Azacitidine / therapeutic use*
-
Drug Resistance, Neoplasm / drug effects*
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / mortality
-
Leukemia, Myeloid, Acute / pathology
-
Male
-
Middle Aged
-
Neoplasm Grading
-
Neoplasm Staging
-
Pioglitazone
-
Prognosis
-
Remission Induction
-
Salvage Therapy*
-
Survival Rate
-
Thiazolidinediones / therapeutic use*
-
Tretinoin / therapeutic use*
Substances
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Tretinoin
-
Azacitidine
-
Pioglitazone